MedTrace Logo

MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy Study

NCT01531725 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 202

Last updated 2013-03-25

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to evaluate safety and efficacy of the BIOTRONIK PRO-Kinetic coronary CoCr-stent in patients with single de novo lesions of native coronary arteries.

Conditions

Interventions

DEVICE

Percutaneous coronary intervention

Percutaneous coronary intervention

Sponsors & Collaborators

  • Biotronik AG

    lead INDUSTRY

Principal Investigators

  • Paul Vermeersch, MD, PhD · ZNA Middelheim, Department Interventional Cardiology

  • Maarten J. Suttorp, MD, PhD · St. Antonius Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2008-04-30
Completion
2009-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01531725 on ClinicalTrials.gov